Work

BYL719, a next generation PI3K alpha specific inhibitor: Preliminary safety, PK, and efficacy results from the first-in-human study

Year: 2012

Type: article

Source: Cancer Research

Authors: Dejan Juric, Jordi Rodón, AM Gonzalez-Angulo, Howard A. Burris, J.C. Bendell, J. Berlin, Mark R. Middleton, Douglas Bootle, Markus Boehm, Antonin Schmitt, Nicolas Rouyrre, Cornelia Quadt, J Baseiga

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3025193256

FWCI: 2.783

Cites:

Cited by: 39

Related to: 10